Aims and objectives

The ESCMID Study Group for Lyme Borreliosis (ESGBOR) plays a pivotal role in the management of Lyme borreliosis and tick-borne diseases. By uniting pan-European experts, we are committed to:

  • Advising healthcare professionals, leaders, and stakeholders on the management of Lyme borreliosis and other tick-borne diseases
  • Reviewing diagnostic and treatment guidelines, and publishing position statements to promote high standards of care
  • Facilitating research initiatives as well as organising thematic meetings and conferences to foster knowledge exchange

Activities and resources

ESGBOR Newsletter April 2023, 4 April 2023 

ESGBOR Newsletter November 2023, 24 November 2023

Identification of potential biomarkers in active Lyme borreliosis. 

Tjernberg I, Lager M, Furset Jensen G, Eikeland R, Nyman D, Brudin L, Henningsson AJ. PLoS ONE. 2023;18(6):e0287586.

Go to publication

ESGBOR symposium – Lyme vaccine and beyond 

13-14 September 2023, Frankfurt, Germany


International symposium on tick-borne pathogens and disease

22-25 October 2023, Vienna, Austria

Go to course

Executive Committee

  Volker Fingerle

Volker Fingerle

Bavarian Health and Food Safety Authority. German National Reference Centre for Borrelia.
Oberschleißheim, Germany
  Anna J. Henningsson

Anna J. Henningsson

Linköping University and Region Jönköping County, Clinical Microbiology
Jönköping, Sweden
  Mateusz Markowicz

Mateusz Markowicz

AGES, Institute for Medical Microbiology and Hygiene
Vienna, Austria


If you have questions or comments for our study group, we warmly invite you to contact us!

Contact form